Literature DB >> 7586619

Elevated serum lipoprotein(a) in subclinical hypothyroidism.

A W Kung1, R W Pang, E D Janus.   

Abstract

OBJECTIVES: Asymptomatic lymphocytic thyroiditis and subclinical hypothyroidism are associated with increased risk for coronary artery disease. The present study aimed at evaluating serum lipoprotein(a)(Lp(a)), measured as apo(a), and other lipid parameters in 32 subjects with asymptomatic subclinical hypothyroidism.
SUBJECTS: Thirty-two Chinese subjects with asymptomatic subclinical hypothyroidism were compared to 96 age and sex-matched healthy controls.
RESULTS: Subclinical hypothyroid patients had higher (P < 0.005) apo(a), total triglyceride (TG), total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) but lower (P < 0.05) high density lipoprotein cholesterol (HDL-C) levels compared with sex and age-matched controls (apo(a) 296 (48-1650) vs 182 (19-1952 U/l), geometric mean (range); TG 1.86 +/- 0.94 vs 1.33 +/- 0.74 mmol/l (mean +/- SD); TC 6.10 +/- 1.17 vs 5.42 +/- 1.13 mmol/l; LDL-C 4.10 +/- 1.00 vs 3.49 +/- 0.96 mmol/l; HDL-C 1.15 +/- 0.40 vs 1.34 +/- 0.40 mmol/l, respectively). APo A-I and apo B were also higher than controls (1.96 +/- 0.48 vs 1.48 +/ 0.29 g/l and 1.44 +/- 0.42 vs 1.05 +/- 0.29 g/l, respectively). Total cholesterol/HDL ratio and LDL/HDL ratio were also elevated in these subjects (5.77 +/- 1.96 vs 4.28 +/- 1.19 and 3.89 +/- 1.41 vs 2.79 +/- 0.97, respectively, both P < 0.0005). Individual analysis revealed that 16 (50%) subjects had hyperlipoproteinaemia (TC > 5.2 mmol/l in 10; TC > 5.2 mmol/l and TG > 2.3 mmol in six) as compared to 21(20.8%) in the control group (P < 0.005). Subjects with TSH > or = 11.0 mIU/l had significantly higher TC/HDL and LDL/HDL ratios. A significant correlation was observed between TSH levels and TC/HDL ratios (r = 0.455, P < 0.01).
CONCLUSIONS: Subclinical hypothyroidism is associated not only with elevated LDL-cholesterol levels and low HDL-cholesterol levels but also with elevated lipoprotein (a). This may further increase the risk development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586619     DOI: 10.1111/j.1365-2265.1995.tb02616.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  15 in total

1.  Are hsCRP Levels and LDL/HDL Ratio Better and Early Markers to Unmask Onset of Dyslipidemia and Inflammation in Asymptomatic Subclinical Hypothyroidism?

Authors:  Mala Mahto; Baidarbhi Chakraborthy; Srinivas H Gowda; Harneet Kaur; Gaurav Vishnoi; Pramod Lali
Journal:  Indian J Clin Biochem       Date:  2012-04-18

2.  Restoration of euthyroidism does not improve cardiovascular risk factors in patients with subclinical hypothyroidism in the short term.

Authors:  Z Beyhan; K Ertürk; G Uçkaya; E Bolu; H Yaman; M Kutlu
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

3.  Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.

Authors:  U M Kabadi; R Cech
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

4.  Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy.

Authors:  Irina Kowalska; Jacek Borawski; Agnieszka Nikołajuk; Tadeusz Budlewski; Elżbieta Otziomek; Maria Górska; Marek Strączkowski
Journal:  Endocrine       Date:  2011-03-18       Impact factor: 3.633

5.  Coronary flow reserve after L-thyroxine therapy in Hashimoto's thyroiditis patients with subclinical and overt hypothyroidism.

Authors:  Huseyin Oflaz; Ramazan Kurt; Fatma Sen; Imran Onur; Arif Oguzhan Cimen; Ali Elitok; Kultigin Turkmen; Burak Pamukcu; Erdem Kasikcioglu; Zehra Bugra; Fehmi Mercanoglu; Nese Ozbey
Journal:  Endocrine       Date:  2008-01-26       Impact factor: 3.633

6.  Effects of thyroid dysfunction on lipid profile.

Authors:  C V Rizos; M S Elisaf; E N Liberopoulos
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

7.  Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.

Authors:  Melpomeni Peppa; Grigoria Betsi; George Dimitriadis
Journal:  J Lipids       Date:  2011-07-18

8.  Association between Perchlorate and Indirect Indicators of Thyroid Dysfunction in NHANES 2001-2002, a Cross-Sectional, Hypothesis-Generating Study.

Authors:  Dina M Schreinemachers
Journal:  Biomark Insights       Date:  2011-12-01

9.  Effects of levothyroxine replacement therapy on parameters of metabolic syndrome and atherosclerosis in hypothyroid patients: a prospective pilot study.

Authors:  Zoran Gluvic; Emina Sudar; Jelena Tica; Aleksandra Jovanovic; Sonja Zafirovic; Ratko Tomasevic; Esma R Isenovic
Journal:  Int J Endocrinol       Date:  2015-03-02       Impact factor: 3.257

10.  Association between primary hypothyroidism and metabolic syndrome and the role of C reactive protein: a cross-sectional study from South India.

Authors:  Ghanshyam Palamaner Subash Shantha; Anita A Kumar; Vijay Jeyachandran; Deepan Rajamanickam; K Rajkumar; Shihas Salim; Kuyilan Karai Subramanian; Senthilkumar Natesan
Journal:  Thyroid Res       Date:  2009-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.